IT201600081420A1 - Batteri lattici e loro uso per il trattamento preventivo, inibitorio,riduttivo della formazione del biofilm batterico - Google Patents

Batteri lattici e loro uso per il trattamento preventivo, inibitorio,riduttivo della formazione del biofilm batterico

Info

Publication number
IT201600081420A1
IT201600081420A1 IT102016000081420A IT201600081420A IT201600081420A1 IT 201600081420 A1 IT201600081420 A1 IT 201600081420A1 IT 102016000081420 A IT102016000081420 A IT 102016000081420A IT 201600081420 A IT201600081420 A IT 201600081420A IT 201600081420 A1 IT201600081420 A1 IT 201600081420A1
Authority
IT
Italy
Prior art keywords
preventive
inhibitor
biofilm formation
reducing treatment
bacterial biofilm
Prior art date
Application number
IT102016000081420A
Other languages
English (en)
Inventor
Giovanni Mogna
Original Assignee
Probiotical Spa
Flame Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa, Flame Srl filed Critical Probiotical Spa
Priority to IT102016000081420A priority Critical patent/IT201600081420A1/it
Priority to CN201780046790.9A priority patent/CN110191945A/zh
Priority to EP17758960.3A priority patent/EP3494206B1/en
Priority to JP2019528179A priority patent/JP2019524159A/ja
Priority to BR112019001984-7A priority patent/BR112019001984A2/pt
Priority to KR1020197006126A priority patent/KR20190103135A/ko
Priority to US16/322,843 priority patent/US20200199692A1/en
Priority to CA3032335A priority patent/CA3032335A1/en
Priority to MA045852A priority patent/MA45852A/fr
Priority to PCT/IB2017/054734 priority patent/WO2018025204A1/en
Priority to RU2019105733A priority patent/RU2019105733A/ru
Publication of IT201600081420A1 publication Critical patent/IT201600081420A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT102016000081420A 2016-08-03 2016-08-03 Batteri lattici e loro uso per il trattamento preventivo, inibitorio,riduttivo della formazione del biofilm batterico IT201600081420A1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT102016000081420A IT201600081420A1 (it) 2016-08-03 2016-08-03 Batteri lattici e loro uso per il trattamento preventivo, inibitorio,riduttivo della formazione del biofilm batterico
CN201780046790.9A CN110191945A (zh) 2016-08-03 2017-08-02 乳酸菌及其在细菌生物膜形成的预防性、抑制性和/或减少性处理中的应用
EP17758960.3A EP3494206B1 (en) 2016-08-03 2017-08-02 Lactic bacteria and the use thereof for the preventive, inhibitory and/or reductive treatment of the formation of bacterial biofilms
JP2019528179A JP2019524159A (ja) 2016-08-03 2017-08-02 細菌バイオフィルムの形成を防止、阻害する及び／又は減弱させる処置のための乳酸菌及びその使用
BR112019001984-7A BR112019001984A2 (pt) 2016-08-03 2017-08-02 bactérias lácticas e a sua utilização para tratamento prevenção, inibição e/ou redução da formação de biofilmes bacterianos
KR1020197006126A KR20190103135A (ko) 2016-08-03 2017-08-02 유산균 및 박테리아 생물막의 형성을 방지, 저해 및/또는 저감 처리하기 위한 이의 용도
US16/322,843 US20200199692A1 (en) 2016-08-03 2017-08-02 Lactic bacteria and the use thereof for the preventive, inhibitory and/or reductive treatment of the formation of bacterial biofilms
CA3032335A CA3032335A1 (en) 2016-08-03 2017-08-02 Lactic bacteria and the use thereof for the preventive, inhibitory and/or reductive treatment of the formation of bacterial biofilms
MA045852A MA45852A (fr) 2016-08-03 2017-08-02 Bactéries lactiques et leur utilisation pour le traitement préventif, inhibiteur et/ou réducteur de la formation de biofilms bactériens
PCT/IB2017/054734 WO2018025204A1 (en) 2016-08-03 2017-08-02 Lactic bacteria and the use thereof for the preventive, inhibitory and/or reductive treatment of the formation of bacterial biofilms
RU2019105733A RU2019105733A (ru) 2016-08-03 2017-08-02 Молочнокислые бактерии и их применение для обработки с целью профилактики, ингибирования и/или уменьшения образования бактериальных биопленок

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000081420A IT201600081420A1 (it) 2016-08-03 2016-08-03 Batteri lattici e loro uso per il trattamento preventivo, inibitorio,riduttivo della formazione del biofilm batterico

Publications (1)

Publication Number Publication Date
IT201600081420A1 true IT201600081420A1 (it) 2018-02-03

Family

ID=57610281

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102016000081420A IT201600081420A1 (it) 2016-08-03 2016-08-03 Batteri lattici e loro uso per il trattamento preventivo, inibitorio,riduttivo della formazione del biofilm batterico

Country Status (11)

Country Link
US (1) US20200199692A1 (it)
EP (1) EP3494206B1 (it)
JP (1) JP2019524159A (it)
KR (1) KR20190103135A (it)
CN (1) CN110191945A (it)
BR (1) BR112019001984A2 (it)
CA (1) CA3032335A1 (it)
IT (1) IT201600081420A1 (it)
MA (1) MA45852A (it)
RU (1) RU2019105733A (it)
WO (1) WO2018025204A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
AU2020279533A1 (en) * 2019-05-20 2021-12-23 L'ORéAL S.A. Composition for treatment, alleviation or prophylaxis of acne
CN110628663B (zh) * 2019-08-02 2021-12-17 华南理工大学 一株鼠李糖乳杆菌及其高密度培养方法和应用
CN112063548A (zh) * 2020-08-19 2020-12-11 杭州医学院 一株具有产蛋白酶能力的植物乳杆菌及其应用
CN113046258B (zh) * 2020-10-09 2023-04-28 江南大学 一株能够预防和/或治疗牙周炎的鼠李糖乳杆菌及其应用
WO2022236527A1 (zh) * 2021-05-10 2022-11-17 合肥工业大学 一种防止不锈钢制品表面有害细菌生物膜形成的方法
CN115039885B (zh) * 2021-05-14 2023-11-03 江苏艾兰得营养品有限公司 一种具有抑制奇异变形杆菌生长作用的副干酪乳杆菌及其益生菌组合物、发酵液和应用
CN113462616A (zh) * 2021-08-19 2021-10-01 上海昊岳食品科技有限公司 一株人源鼠李糖乳杆菌glr8及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2455095A1 (en) * 2009-07-16 2012-05-23 Hiroshima University Prophylactic, ameliorating or therapeutic agent for oral diseases
US20140186409A1 (en) * 2011-05-06 2014-07-03 Organobalance Medical Ag Novel lactic acid bacteria and compositions containing them

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2999601B1 (fr) * 2012-12-17 2015-01-30 Urgo Lab Methode pour prevenir et/ou traiter les infections, colonisations ou maladies liees a staphylococcus aureus, pseudomonas aeruginosa, streptococcus pyogenes, enterococcus faecium, enterobacter cloacae, proteus mirabilis et/ou bacteroides fragilis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2455095A1 (en) * 2009-07-16 2012-05-23 Hiroshima University Prophylactic, ameliorating or therapeutic agent for oral diseases
US20140186409A1 (en) * 2011-05-06 2014-07-03 Organobalance Medical Ag Novel lactic acid bacteria and compositions containing them

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CLAUDIA VUOTTO ET AL: "Probiotics to counteract biofilm-associated infections: promising and conflicting data", INTERNATIONAL JOURNAL OF ORAL SCIENCE, vol. 6, no. 4, 26 September 2014 (2014-09-26), CN, pages 189 - 194, XP055284950, ISSN: 1674-2818, DOI: 10.1038/ijos.2014.52 *
MATSUBARA VICTOR HARUO ET AL: "Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, SPRINGER, DE, vol. 100, no. 14, 18 April 2016 (2016-04-18), pages 6415 - 6426, XP035986577, ISSN: 0175-7598, [retrieved on 20160418], DOI: 10.1007/S00253-016-7527-3 *
VALDÉZ J C ET AL: "Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment", CLINICAL MICROBIOLOGY AND INFECTION, WILEY-BLACKWELL PUBLISHING LTD, UNITED KINGDOM, SWITZERLAND, vol. 11, no. 6, 1 June 2005 (2005-06-01), pages 472 - 479, XP002511012, ISSN: 1198-743X, DOI: 10.1111/J.1469-0691.2005.01142.X *
W. MOHAMMEDSAEED ET AL: "Lactobacillus rhamnosus GG Inhibits the Toxic Effects of Staphylococcus aureus on Epidermal Keratinocytes", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 80, no. 18, 15 September 2014 (2014-09-15), US, pages 5773 - 5781, XP055347831, ISSN: 0099-2240, DOI: 10.1128/AEM.00861-14 *

Also Published As

Publication number Publication date
WO2018025204A1 (en) 2018-02-08
JP2019524159A (ja) 2019-09-05
EP3494206B1 (en) 2021-07-07
EP3494206A1 (en) 2019-06-12
CN110191945A (zh) 2019-08-30
RU2019105733A (ru) 2020-09-04
KR20190103135A (ko) 2019-09-04
BR112019001984A2 (pt) 2019-05-07
US20200199692A1 (en) 2020-06-25
CA3032335A1 (en) 2018-02-08
MA45852A (fr) 2019-06-12

Similar Documents

Publication Publication Date Title
IT201600081420A1 (it) Batteri lattici e loro uso per il trattamento preventivo, inibitorio,riduttivo della formazione del biofilm batterico
IL271085B2 (en) Bacteria to treat disorders
MD3209310T2 (ro) Compoziții care conțin tulpini bacteriene
MD3209381T2 (ro) Compoziții care conțin tulpini bacteriene
WO2015003816A3 (en) Cystobactamides
PT3220741T (pt) Composição e kits para a inibição de uma infecção microbiana patogénica e métodos de utilização da mesma
HRP20190580T1 (hr) Kombinirana terapija radi liječenja rezistentnih bakterijskih infekcija
MX2017010150A (es) Bacterias probioticas recombinantes.
EA201691421A1 (ru) Гетероарилы и их применение
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
GB2548277A (en) Antibiofilm compositions
IL286488A (en) Bacteria oxidize ammonia to treat acne
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
IL281775A (en) Methods of treating infections using bacteria
ITUA20162013A1 (it) Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
IL281770A (en) History of indan for the treatment of bacterial infection
SG11201702011SA (en) Agent for promoting growth of nonpathogenic oral indigenous bacteria or agent for improving oral bacterial flora, and composition for oral use
IN2013MU03216A (it)
PT3565551T (pt) Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem
IT201700086482A1 (it) Composizione per il trattamento della vaginosi batterica
MX2018004091A (es) Antagonistas de il-17c para el tratamiento y/o prevencion de dermatitis atopica.
SG11202003009QA (en) Methods of treating bacterial infections
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
EP3450556A4 (en) PEPTIDE INHIBITING COLONIZATION OF PATHOGENIC BACTERIA AND COLONIZATION INHIBITOR COMPRISING SAME
GB201619704D0 (en) Treatment of pathogenic infections